Arrowhead Pharmaceuticals
ARWR
#2176
Rank
S$11.00 B
Marketcap
S$79.62
Share price
-4.98%
Change (1 day)
166.74%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) Fails to deliver data

Key failure to deliver metrics for Arrowhead Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Arrowhead Pharmaceuticals (ARWR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Arrowhead Pharmaceuticals (ARWR) - since 2016

Volume in USD (price x number of shares), data since 2016

Arrowhead Pharmaceuticals (ARWR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$6.97 M-28.76%
2024S$9.79 M55.71%
2023S$6.28 M39.55%
2022S$4.5 M-73.07%
2021S$16.73 M-49.26%
2020S$32.99 M-52.98%
2019S$70.16 M188.2%
2018S$24.34 M233.16%
2017S$7.3 M-4.53%
2016S$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Alnylam Pharmaceuticals
ALNY
S$13.72 MS$39.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$2.41 MS$9.29 M๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
S$5.35 MS$9.85 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$54.31 MS$94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S$6.56 MS$53.78 M๐Ÿ‡บ๐Ÿ‡ธ USA